The company was founded as a German limited liability company (GmbH) by university professor and doctor of medicine Hans Rommelspacher in Berlin on 13
th August 2010. In recent years he was the Head of Clinical Neurobiology at the Psychiatric Clinic of the Charité university hospital. He worked for over 20 years there on the effects of the primary compound used here. In the past few years extensive structure-activity experiments have been able to prove the neuroprotective and neuroregenerative, or therapeutic, potential of some derivatives in established animal models of Parkinson’s disease and in cell cultures.
Along with NanoPet Pharma Berlin and Wildau Technical University of Applied Sciences, AudioCure Pharma founded the NeuroPro Alliance research network. It is partially financed by the German Federal Ministry of Education and Research.
Funding Rounds (1) - undisclosedUpdate
|May 29, 2012||FinSMEs - AudioCure Pharma raises 0 in seed round|
Berlin, Berlin 10115